haylaavo

SHARONBIO

SHARONBIO · NSE · inactive
3.30
-0.15 (-4.35%)
as of 28 Mar 2019 close
Open
3.30
High
3.30
Low
3.30
Prev close
3.45
52w high
7.40
14 Sept 2018
52w low
2.75
06 Aug 2018
VWAP
3.30
Delivery %
—
n/a
Volume 8,834 · turnover ₹29,152 · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 07 Dec 2011
Series
BZ
F&O
No
Status
Inactive since 29 Mar 2019

Source: NSE equity master · as of 28 Mar 2019

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 03:56 IST
  • 16 Jun 2023 18:25
    Results

    The Exchange has sought clarification from Sharon Bio-Medicine Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.

  • 30 May 2023 20:09
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023.

    PDF · -
  • 10 Feb 2023 17:42
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.

    PDF · -
  • 17 May 2022 17:56
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

    PDF · -
  • 07 Feb 2022 15:17
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.

    PDF · -
  • 03 Nov 2021 13:45
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.

    PDF · -
  • 13 Aug 2021 16:28
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.

    PDF · -
  • 23 Jun 2021 16:19
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.

    PDF · -
  • 12 Feb 2021 16:11
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.

    PDF · -
  • 11 Nov 2020 18:20
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.

    PDF · -
  • 11 Sept 2020 13:57
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.

    PDF · -
  • 30 Jul 2020 22:58
    Results

    The Exchange has sought clarification from Sharon Bio-Medicine Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.

  • 26 Jun 2020 18:55
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

    PDF · -
  • 12 Feb 2020 19:58
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.

    PDF · -
  • 14 Nov 2019 19:15
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.

    PDF · -
  • 14 Aug 2019 16:48
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.

    PDF · -
  • 12 Jun 2019 12:14
    Results

    The Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.

    PDF · -
  • 30 May 2019 20:52
    Results

    The Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

  • 24 May 2019 20:35
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.

    PDF · -
  • 14 Feb 2019 16:46
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

    PDF · -
  • 14 Nov 2018 19:34
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

    PDF · -
  • 14 Aug 2018 18:26
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

    PDF · -
  • 07 Jun 2018 20:31
    Results

    The Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.

    PDF · -
  • 04 Jun 2018 20:26
    Results

    The Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

  • 31 May 2018 12:04
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

    PDF · -
  • 22 Feb 2018 20:20
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.

    PDF · -
  • 22 Feb 2018 20:17
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.

    PDF · -
  • 22 Feb 2018 20:14
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2017.

    PDF · -
  • 27 Dec 2017 16:23
    Results

    The Exchange had sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Financial results not submitted as per Ind-AS format. -4. Reconciliation of profit and loss not submitted. -5. Reconciliation of Equity not submitted

    PDF · -
  • 11 Dec 2017 14:43
    Results

    The Exchange has sought clarification from Sharon Bio-Medicine Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Financial results not submitted as per Ind-AS format. -4. Reconciliation of profit and loss not submitted. -5. Reconciliation of Equity not submitted T

  • 08 Dec 2017 16:59
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended 31-Mar-2017.

    PDF · -
  • 13 Feb 2017 16:44
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2016.

    PDF · -
  • 10 Nov 2016 18:13
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended 30-Sep-2016.

    PDF · -
  • 11 Aug 2016 17:41
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2016.

    PDF · -
  • 30 May 2016 18:34
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended .

    PDF · -
  • 15 Feb 2016 14:28
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.

    PDF · -
  • 10 Nov 2015 15:01
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015.

    PDF · -
  • 31 Aug 2015 09:41
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results along with the Auditors Report for the period ended 30-Jun-2015.

    PDF · -
  • 14 May 2015 20:43
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2015.

    PDF · -
  • 16 Feb 2015 08:51
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Dec-2014.

    PDF · -
  • 13 Nov 2014 18:47
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.

    PDF · -
  • 01 Sept 2014 09:47
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Jun-2014.

    PDF · -
  • 15 May 2014 15:19
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2014.

    PDF · -
  • 10 Feb 2014 10:51
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results for the period ended 31-dec-2013.

    PDF · -
  • 12 Nov 2013 21:07
    Results

    Sharon Bio-Medicine Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2013.

    PDF · -
  • 30 Aug 2013 10:52
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended June 30,2013.

    PDF · -
  • 15 May 2013 16:45
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended March 31,2013.

    PDF · -
  • 14 Feb 2013 18:01
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012.

    PDF · -
  • 13 Nov 2012 17:30
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.

    PDF · -
  • 14 Aug 2012 14:53
    Results

    Sharon Bio-Medicine Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2012.

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries